NeoSoma has filed a notice of an exempt offering of securities to raise $2,100,000.00 in New Debt Financing.
According to filings with the U.S. Securities and Exchange Commission, NeoSoma is raising $2,100,000.00 in new funding. Sources indicate that as part of senior management President, Kenneth Kolodziej played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About NeoSoma
At Neosoma, we stand at the crossroads where cutting-edge science meets compassionate care. Our mission is to design and deploy clinician-centric, A.I. powered neurodiagnostic solutions. Our advanced tools cater to neuroradiologists, radiation oncologists, neurologists, neurosurgeons, and neuroscience researchers. Our prime objective is to enhance the research, diagnosis, treatment, and clinical trials pertaining to brain cancers. Our patented, FDA-approved technology offerings bridge the gap between raw data and actionable insights. They ensure the right, precise information is at the physicians fingertips exactly when its needed. Moreover, our solutions integrate smoothly within existing workflows and facilitate seamless collaboration amongst all the professionals engaged in the care of brain cancer patients. At Neosoma, we draw our strength from the seasoned practicing physicians and software industry veterans who form our leadership. This unique blend enables us to develop world-class software that prioritizes the needs of both patients and physicians. We firmly believe this patient-centric, physician-first approach will trigger the most substantial positive impact on our patients health outcomes and resonate profoundly within our community. Our collaborations extend to some of the most progressive and innovative health systems across the US. We invite you to explore how our FDA-approved technologies can catalyze the growth and effectiveness of your NeurOnc. Practice. Please get in touch to learn more about the difference Neosoma can make!
To learn more about NeoSoma, visit http://www.neosomainc.com/
Contact:
Kenneth Kolodziej, President
617-888-4080
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.